Digital Digital twins in healthcare and drug discovery: From idea to... The term "digital twins" has its origins in engineering and computer science, where it refers to a virtual replica of a physical object or system.
Digital AI in Drug Discovery: Day One There is no denying that artificial intelligence (AI) has captured the imagination of innovators working across the pharmaceutical sector.
News MSD stops trials of BTK inhibitor for blood cancers MSD has stopped development of BTK inhibitor nemtabrutinib, acquired via its $2.7bn takeover of ArQule, after trial results pointed to a safety issue.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.